Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
The current Moderna(MRNA) stock price is $29.31, with a market capitalization of 11.75B. The stock trades at a price-to-earnings (P/E) ratio of -3.65.
During the trading session on 2025-12-13, Moderna(MRNA) shares reached a daily high of $30.44 and a low of $29.21. At a current price of $29.31, the stock is +0.3% higher than the low and still -3.7% under the high.
Trading activity shows a volume of 12.31M, compared to an average daily volume of 9.56M.
The stock's 52-week range extends from a low of $22.28 to a high of $48.92.
The stock's 52-week range extends from a low of $22.28 to a high of $48.92.
MRNA News
Morgan Stanley lowered the firm’s price target on Moderna (MRNA) to $28 from $30 and keeps an Equal Weight rating on the shares. The firm expects many of the po...
Moderna (MRNA) has received a new Hold rating, initiated by Jefferies analyst, Andrew Tsai. TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-b...
Moderna (NASDAQ:MRNA) extended gains for the seventh consecutive trading session, with the stock closing 2.14% higher at $29.65 on Thursday. MRNA has added 20....
Analyst ratings
62%
of 26 ratingsMore MRNA News
The US risks falling behind in biotechnology as the government cuts funding and skepticism over vaccines grows, according to Moderna Inc.’s co-founder and Chair...
Moderna, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Salveen Richter from Goldman Sachs maintained a Hold rating on...
Mixed options sentiment in Moderna (MRNA), with sharesflat near $27.70. Options volume relatively light with 44k contracts traded and calls leading puts for a p...